Report: Collins to lead NIH

Francis Collins, the geneticist who led the Human Genome Project, is close to taking over the top spot at the National Institutes of Health, according to a linkurl:report;http://www.latimes.com/features/health/la-na-nih-collins23-2009may23,0,5889122.story by __Bloomberg News__. Collins, who was the director of the NIH's National Human Genome Research Institute from 1993 to 2008, is in the final stages of being screened by the administration of US President Barack Obama, an unnamed source told _

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Francis Collins, the geneticist who led the Human Genome Project, is close to taking over the top spot at the National Institutes of Health, according to a linkurl:report;http://www.latimes.com/features/health/la-na-nih-collins23-2009may23,0,5889122.story by __Bloomberg News__.
Collins, who was the director of the NIH's National Human Genome Research Institute from 1993 to 2008, is in the final stages of being screened by the administration of US President Barack Obama, an unnamed source told __Bloomberg__. Elias Zerhouni, Collins' would-be predecessor, voiced his approval for the pick, telling __Bloomberg__ that Collins has "done things many scientists wish they could do once in their lifetime, and he's done it repeatedly." Collins recently unveiled a new foundation, BioLogos, that promotes "the search for truth in both the natural and spiritual realms, and seeks to harmonize these different perspectives," according to the organization's linkurl:Web site.;http://biologos.org/ Collins, who is an evangelical Christian, has linkurl:said;http://www.usnews.com/blogs/god-and-country/2009/05/04/francis-collins-a-scientific-basis-for-god.html that his new foundation is an attempt to resolve Christian faith with scientific evidence, especially with regard to evolution. In 2006 he published a bestselling book, __The Language of God: A Scientist Presents Evidence for Belief__, that stirred some controversy in the scientific community.
**__Related stories:__***linkurl:FDA head chosen, NIH names swirling;http://www.the-scientist.com/blog/display/55507/
[12th March 2009]*linkurl:Collins to industry, top of NIH?;http://www.the-scientist.com/blog/display/54702/
[28th May 2008]*linkurl:Francis Collins leaves NHGRI;http://www.the-scientist.com/blog/display/54701/
[28th May 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies